AstraZeneca to elevate New York listing in blow to London
UK drugmaker says it intends to create a ‘global listing for a global company’

The US Dollar (USD) came under renewed downside pressure, partially eroding the previous week’s strong uptick, as investors continued to pencil in the likelihood that the Federal Reserve could lower its interest rates once again at its December 10 gathering.
After rising more than 3.5% in the previous week, Gold (XAU/USD) has entered a consolidation phase and fluctuated at around $4,200.